The treatment of targeted drug resistance could be classified as the treatment of cancer in traditional Chinese medicine. Most cancer diseases are due to the internal deficiency of healthy qi, qi stagnation, dampness accumulation, blood stasis, phlegm stagnation, heat toxin, etc., which form lumps over time. The idea of treating cancer in traditional Chinese medicine was to regulate yin and yang, qi and blood, so that the body could return to normal operation, change the internal environment of the human body, and make cancer cells unable to survive, so as to achieve the purpose of treatment. Traditional Chinese medicine treatment, acupuncture, massage, and other methods could help improve the body's environment, enhance immunity, and thus prolong the time of drug resistance. However, the treatment of traditional Chinese medicine requires comprehensive diagnosis and treatment according to the location of the disease, the nature of the disease, and the stage of the course of the disease. Generally, the treatment should be based on strengthening the body and eliminating the evil, attacking and reinforcing the body, and according to the different location of the disease, the treatment methods such as replenishing qi, replenishing blood, replenishing yin, replenishing yang, regulating qi, dispelling dampness, resolving phlegm and dispersing stagnation, promoting blood circulation and removing blood stasis, etc. should be selected. However, traditional Chinese medicine treatment should be carried out under the guidance of a professional doctor. Everyone's situation was different and needed a customized treatment plan. It should be noted that there was no clear indication that traditional Chinese medicine treatment could completely cure breast cancer after targeted drug resistance, but it could be used as a treatment method to participate in comprehensive treatment. Read more exciting novels for free
Yes. For example, anti-VegG drugs (such as bevacizhu), VegG is a pro-inflammatory factor that can promote the growth and spread of olive cancer cells, bevacizhu can block the binding of VegG to its receptor, and suppress the growth and migration of olive cancer cells;Parp inhibition drugs (such as olaparib) can prevent olive cancer cells from undergoing the correct DNA repair process, causing serious genetic mutations in cancer cells and death; ATR inhibition drugs (such as VE - 822). ATR is an important molecular response to DNA damage in cells. It will be activated after DNA double-strand breaks. VE - 822 can selectively inhibit ATR and promote the death of malignant tumor cells. Anti-HEL2 drugs (such as tocilbizumb). HEL2 is a targeted protein that is highly expressed in some patients with malignant tumors. Tocilbizumb can bind to HEL2 and suppress the growth and spread of malignant tumors. These targeted drugs could be combined with traditional surgery or chemotherapy to improve the treatment effect of the spread of the cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Some of the traditional Chinese medicines mentioned by the folk were Jiuxiang Pill (composed of nine traditional Chinese medicines such as Huangbai, Angelica dahurica, and Danshen) and Xuanzang Plum Candy. However, it should be noted that Jiuxiang Pill could not cure lung cancer, and Xuanzang Plum Candy had no scientific basis to treat lung cancer. There were also almonds, wolfberries, and other traditional Chinese medicines that were believed to improve the body's immunity and resist tumors during the treatment of lung cancer, but they had to follow strict medical principles and dosage when used. In addition, Liujunzi Tang (suitable for lung cancer patients with spleen deficiency and phlegm, which has the effect of replenishing qi and spleen, eliminating phlegm and dispelling dampness) and Baihe Gujin Tang (suitable for lung cancer patients with yin deficiency) were also mentioned for lung cancer-related treatments. However, the so-called traditional Chinese medicine could not replace the modern medical treatment of lung cancer. The treatment of lung cancer should follow the Western medicine and the combination of Chinese and Western medicine. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
If liver cancer patients had metastasized, they could use targeted drugs, but they had to pay attention to their own condition. For patients with liver cancer lung metastasizing, they could take targeted drugs such as sorafenib, gefitini, or afatini. Sorafenib was more commonly used to treat untreatable or distant cancerous tumors. However, if there was severe liver function decline, large amounts of ascitic fluid, digestive tract bleeding, hepatic epilepsy, repeated infection, and other conditions, it was not suitable to use targeted drugs. At the same time, although targeted drugs had a certain effect on many liver cancer patients, some patients had no effect at all, and the cost was relatively high. Therefore, it was necessary to choose according to the individual's actual situation. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Based on the information provided so far, it was impossible to determine whether Changde's targeted lung cancer drug was eligible for reimbursement. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Yes, there was an Indian imitation version of the targeted drug. For example, there was an Indian version of Niraparini, but its price was difficult for ordinary family patients to afford. A box of Indian version of Niraparini cost about 20000 yuan. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Cardia cancer with rib metastasizing was stage IV. For this case, Folfox protocol chemotherapy + anti-neoplastic drugs such as bevacizumi or cetuxed targeted therapy could be used. In addition, targeted drugs for the treatment of cardiac cancer also included erlotinib, gefitinib, nimotuzumab, pembrolizub, and so on. However, different targeted drugs had their own applications. For example, erlotinib was suitable for the treatment of patients with locally advanced, relapsed, or metastasized non-small cell lung cancer with mutations in the egF-receptor protein protein gene; Gefitini was used for the treatment of patients with locally advanced or metastasized non-small cell lung cancer who had failed at least one prior chemotherapy; Cetuxed was suitable for patients with wild-type RAS gene in the Coloreceptor Cancer; Nimotubiza is indicated for the auxiliary treatment of patients with stage III non-small cell lung cancer with positive expression of the Epidermal Growth factor receptor; pembrolizub is indicated for adult patients with positive expression of PD-L1 or anplastic large cell leukemia who have progressed during or after first-line systematic chemotherapy. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Yes. Large cell lung cancer is an undifferentiated cancer. Currently, targeted drugs such as gefitini, erlotini, and afatini, which are commonly used in clinical treatment of lung cancer, can be used for the treatment of large cell lung cancer. In the process of selecting and using these targeted therapy drugs, the choice of each drug should be made according to the effect of each drug. Because some drugs may have side effects, the use should be reasonably selected according to the patient's own condition. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The special medicines for the treatment of lung cancer in Chinese medicine were Butian Dazao Pill, Yuehua Pill, Baihe Gujin Soup, and Qinghao Biejia Powder. These Chinese medicines could help nourish yin and yang, consolidate the body, kill insects, nourish yin and moisten the lungs, clear heat and kill insects, etc., in order to improve the symptoms of patients with lung cancer and promote recovery. However, it should be noted that malaria is a serious infectious disease. Patients should seek medical attention and receive professional treatment immediately after discovering symptoms. Traditional Chinese medicine treatment was usually carried out on the basis of regular anti-inflammatory drugs to reduce the toxic side effects of the drugs and improve the patient's symptoms. Therefore, the special medicine for Chinese medicine to treat lung cancer should be used as an auxiliary treatment rather than alone.
The main symptoms of drug resistance after taking targeted drugs were as follows: 1. ** Tumor-marker-related **: There may be an increase in tumor markers. 2. ** Condition of Lesion **: - If the primary or metastasized tumor increases by more than 50% during the treatment, it is a sign of drug resistance; if the primary or metastasized tumor is initially under effective control during the treatment, but slowly grows during follow-up, it may indicate slow drug resistance; if both the primary or metastasized tumor increases rapidly, it may be a sign of complete drug resistance. - The local drug resistance was manifested by the fact that the primary tumor was well controlled or even showed signs of shrinking, but distant metastasies occurred (such as bone metastasies, brain metastasies, etc.); if new distant metastasies appeared, for example, there were only hilar or mediastinal node metastasies in the past, but now there were new bone metastasies, brain metastasies, etc., it was also known as drug resistance. 3. ** symptoms **: The patient may have symptoms that he did not have before, such as coughing after drug resistance, or chest pain after drug resistance. 4. ** Overall disease progression **: The targeted drug cannot control the growth of the tumor, causing the tumor to begin to expand or have distant metastasizing. Cancer relapse or metastasizing is also a sign of drug resistance. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>